Creation of an arteriovenous fistula is associated with significant acute local and systemic changes in microvascular function

Nephron - Clinical Practice

Volumn 123, Issue 3-4, 2013, Pages 173-179

  Korsheed, S ^a   Crowley, L E ^a   Fluck, R J ^a   McIntyre, C W ^a,b  

^a ROYAL DERBY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acetylcholine; Arteriovenous fistula; Endothelial dysfunction; Microvascular function; Sodium nitroprusside

Indexed keywords

AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD FLOW; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ELBOW; END TO SIDE ANASTOMOSIS; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IONTOPHORESIS; MALE; MICROVASCULARIZATION; PATIENT REFERRAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCINTIGRAPHY; SHEAR STRESS; VASODILATATION; WRIST; CARDIOVASCULAR FUNCTION; CHRONIC KIDNEY DISEASE; HEMODIALYSIS; LASER DOPPLER FLOWMETRY; MICROVASCULAR FUNCTION; PERFUSION;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT, SURGICAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IONTOPHORESIS; MALE; MICROCIRCULATION; MIDDLE AGED; RENAL DIALYSIS; VASODILATION;

EID: 84880982872     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000353708     Document Type: Article

References (37)

1. I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis 2001; 37(suppl 1):S7-S64.
2. Polkinghorne KR, McDonald SP, Atkins RC, et al: Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-486.
3. Veves A, Akbari CM, Primavera J, et al: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998; 47: 457-463.
4. Arora S, Pomposelli F, LoGerfo FW, et al: Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002; 35: 501-505.
5. Parving HH, Nielsen FS, Bang LE, et al: Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 1996; 39: 1590-1597.
6. Lockette W, Otsuka Y, Carretero O: The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8:II61-II66.
7. Van de Voorde J, Vanheel B, Leusen I: Depressed endothelium-dependent relaxation in hypertension: relation to increased blood pressure and reversibility. Pflugers Arch 1988; 411: 500-504.
8. Luscher TF, Yang ZH, Diederich D, et al: Endothelium- derived vasoactive substances: potential role in hypertension, atherosclerosis, and vascular occlusion. J Cardiovasc Pharmacol 1989; 14(suppl 6):S63-S69.
9. Flaud P, Simon A, Pithois-Merli I, et al: Non invasive evaluation of endothelial shearing phenomena in human arteries. Application to essential hypertension (in French). Arch Mal Coeur Vaiss 1989; 82: 1073-1075.
10. Spieker LE, Noll G, Ruschitzka FT, et al: Working under pressure: the vascular endothelium in arterial hypertension. J Hum Hypertens 2000; 14: 617-630.
11. Thambyrajah J, Landray MJ, McGlynn FJ, et al: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 2000; 83: 205-209.
12. Bolton CH, Downs LG, Victory JG, et al: Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1189-1197.
13. Foley R: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 2003; 16: 111-117.
14. Kalantar-Zadeh K, Block G, Humphreys MH, et al: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
15. Harnett J, Foley R, Kent G, et al: Congestive heart failure in dialysis patients: prevalence, ncidence, prognosis and risk factors. Kidney Int 1995; 47: 884-890.
16. Cheung A, Sarnak M, Yan G, et al: Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 2004; 65: 2380-2389.
17. Ragosta M, Samady H, Isaacs R, et al: Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 2004; 147: 1017-1023.
18. McIntyre CW: Effects of hemodialysis on cardiac function. Kidney Int 2009; 76: 371-375.
19. McIntyre CW, Burton JO, Selby NM, et al: Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3: 19-26.
20. Hothi DK, Rees L, Marek J, Burton J, Mc-Intyre CW: Pediatric myocardial stunning underscores the cardiac toxicity of conventional hemodialysis treatments. Clin J Am Soc Nephrol 2009; 4: 790-797.
21. Pignocchino P, Conte MR, Scarnato S, et al: Study of cutaneous microcirculation using the laser-Doppler method in syndrome X (in Italian). Cardiologia 1994; 39: 193-197.
22. Economides PA, Caselli A, Zuo CS, et al: Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 2004; 53: 222-227.
23. Kruger A, Stewart J, Sahityani R, et al: Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int 2006; 70: 157-164.
24. Stewart G, Mark P, Johnston N, et al: Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 2004; 24: 387-393.
25. Droog EJ, Henricson J, Nilsson GE, et al: A protocol for iontophoresis of acetylcholine and sodium nitroprusside that minimises nonspecific vasodilatory effects. Microvasc Res 2004; 67: 197-202.
26. Klonizakis M, Yeung JM, Nash JR, et al: Effects of posture and venous insufficiency on endothelial-dependent and -independent cutaneous vasodilation in the perimalleolar region. Eur J Vasc Endovasc Surg 2003; 26: 100-104.
27. Farkas K, Nemcsik J, Kolossvary E, et al: Impairment of skin microvascular reactivity in hypertension and uraemia. Nephrol Dial Transplant 2005; 20: 1821-1827.
28. Vequaud P, Pourageaud F, Freslon JL: Role of nitric oxide and endothelium in the flow-induced dilation of rat coronary arteries under two preconstriction conditions. Clin Exp Pharmacol Physiol 1999; 26: 470-476.
29. Kuchan MJ, Frangos JA: Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 1994; 266:C628-C636.
30. Dimmeler S, Haendeler J, Rippmann V, et al: Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 1996; 399: 71-74.
31. Davies PF, Remuzzi A, Gordon EJ, et al: Turbulent fluid shear stress induces vascular endothelial ell turnover in vitro. Proc Natl Acad Sci USA 1986; 83: 2114-2117.
32. Levesque MJ, Liepsch D, Moravec S, et al: Correlation of endothelial cell shape and wall shear stress in a stenosed dog aorta. Arteriosclerosis 1986; 6: 220-229.
33. Reidy MA, Bowyer DE: Scanning electron microscopy of arteries: the morphology of aortic endothelium in haemodynamically stressed areas associated with ranches. Atherosclerosis 1977; 26: 181-194.
34. Sato M, Ohshima N: Flow-induced changes in shape and cytoskeletal structure of vascular endothelial cells. Biorheology 1994; 31: 143-153.
35. Hsiai TK, Cho SK, Honda HM, et al: Endothelial cell dynamics under pulsating flows: significance of high versus low shear stress slew rates (d(tau)/dt). Ann Biomed Eng 2002; 30: 646-656.
36. Dammers R, Tordoir JH, Kooman JP, et al: The effect of flow changes on the arterial system proximal to an arteriovenous fistula for hemodialysis. Ultrasound Med Biol 2005; 31: 1327-1333.
37. Korsheed S, Eldehni MT, John SG, et al: Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant 2011; 26: 3296-3302.